Diagonal Therapeutics’ Post

View organization page for Diagonal Therapeutics, graphic

3,689 followers

June is hereditary hemorrhagic telangiectasia (HHT) awareness month. HHT is a genetic orphan disease that affects more than 150,000 patients in the US and EU. The disease causes frequent bleeding that leads to transfusion-dependent anemia in the majority of patients. It's underdiagnosed and often misunderstood, which is why awareness is so important! At Diagonal, we are advancing therapies that we believe can treat the underlying cause of HHT. Throughout June, join us in raising awareness of HHT and learn more by visiting: www.curehht.org #HHTAwarenessMonth #HHTAwareness

  • No alternative text description for this image
Juliane Mills

Therapeutic Strategy, Rare Disease | MS Public Health | MS Science Communication

4mo

Very excited for this research to support the HHT community!!

Marianne Sergott Clancy

Executive Director at Cure HHT/ Senior Director of Research and Medical Strategic Partnerships

4mo

Thank you for expanding our message!

See more comments

To view or add a comment, sign in

Explore topics